Literature DB >> 30236282

A Cortical Pathogenic Theory of Parkinson's Disease.

Guglielmo Foffani1, José A Obeso2.   

Abstract

In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic neurons in the substantia nigra pars compacta (SNc) is associated with classic motor features, which typically have a focal onset. Since a defined somatotopic arrangement in the SNc has not been recognized, this focal motor onset is unexplained and hardly justified by current pathogenic theories of bottom-up disease progression (Braak's hypothesis, prionopathy). Here we propose that corticostriatal activity may represent a critical somatotopic "stressor" for nigrostriatal terminals, ultimately driving retrograde nigrostriatal degeneration and leading to focal motor onset and progression of Parkinson's disease. As a pathogenic mechanism, corticostriatal activity may promote secretion of striatal extracellular alpha-synuclein, favoring its pathological aggregation at vulnerable dopaminergic synapses. A similar pathogenic process may occur at corticofugal projections to the medulla oblongata and other vulnerable structures, thereby contributing to the bottom-up progression of Lewy pathology. This cortical pathogenesis may co-exist with bottom-up mechanisms, adding an integrative top-down perspective to the quest for the factors that impinge upon the vulnerability of dopaminergic cells in the onset and progression of Parkinson's disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; alpha-synuclein; basal ganglia; cortex; corticostriatal; dopamine; nigrostriatal; somatotopy

Mesh:

Substances:

Year:  2018        PMID: 30236282     DOI: 10.1016/j.neuron.2018.07.028

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  26 in total

1.  A Neural Signature of Parkinsonism in Patients With Schizophrenia Spectrum Disorders: A Multimodal MRI Study Using Parallel ICA.

Authors:  Robert C Wolf; Mahmoud Rashidi; Stefan Fritze; Katharina M Kubera; Georg Northoff; Fabio Sambataro; Vince D Calhoun; Lena S Geiger; Heike Tost; Dusan Hirjak
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

2.  AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.

Authors:  Pathik Parekh; Nishant Sharma; Monika Sharma; Anagha Gadepalli; Adil Ali Sayyed; Sayan Chatterjee; Abhijeet Kate; Amit Khairnar
Journal:  Metab Brain Dis       Date:  2022-09-30       Impact factor: 3.655

3.  The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.

Authors:  Erinc Hallacli; Can Kayatekin; Sumaiya Nazeen; Xiou H Wang; Zoe Sheinkopf; Shubhangi Sathyakumar; Souvarish Sarkar; Xin Jiang; Xianjun Dong; Roberto Di Maio; Wen Wang; Matthew T Keeney; Daniel Felsky; Jackson Sandoe; Aazam Vahdatshoar; Namrata D Udeshi; D R Mani; Steven A Carr; Susan Lindquist; Philip L De Jager; David P Bartel; Chad L Myers; J Timothy Greenamyre; Mel B Feany; Shamil R Sunyaev; Chee Yeun Chung; Vikram Khurana
Journal:  Cell       Date:  2022-06-09       Impact factor: 66.850

4.  Clinicopathological correlates of pyramidal signs in multiple system atrophy.

Authors:  Chi-Ying R Lin; Anisha Viswanathan; Tiffany X Chen; Hiroshi Mitsumoto; Jean P Vonsattel; Phyllis L Faust; Sheng-Han Kuo
Journal:  Ann Clin Transl Neurol       Date:  2022-05-20       Impact factor: 5.430

5.  Onset pattern of nigrostriatal denervation in early Parkinson's disease.

Authors:  José A Pineda-Pardo; Álvaro Sánchez-Ferro; Mariana H G Monje; Nicola Pavese; José A Obeso
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

Review 6.  The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene.

Authors:  Tamara Kobiec; Matilde Otero-Losada; Guenson Chevalier; Lucas Udovin; Sofía Bordet; Camila Menéndez-Maissonave; Francisco Capani; Santiago Pérez-Lloret
Journal:  Front Synaptic Neurosci       Date:  2021-04-22

7.  The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.

Authors:  Hanjiang Luo; Caixia Peng; Xiaofeng Xu; Yuntao Peng; Fang Shi; Qinghua Li; Jianghui Dong; Min Chen
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

8.  TNFα increases tyrosine hydroxylase expression in human monocytes.

Authors:  Adithya Gopinath; Martin Badov; Madison Francis; Gerry Shaw; Anthony Collins; Douglas R Miller; Carissa A Hansen; Phillip Mackie; Malú Gámez Tansey; Abeer Dagra; Irina Madorsky; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-07-20

9.  Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates.

Authors:  Leonardo Acuña; Sabah Hamadat; Natalia S Corbalán; Florencia González-Lizárraga; Mauricio Dos-Santos-Pereira; Jérémy Rocca; Julia Sepúlveda Díaz; Elaine Del-Bel; Dulce Papy-García; Rosana N Chehín; Patrick P Michel; Rita Raisman-Vozari
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

10.  A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson's disease.

Authors:  Meir Schechter; Jessica Grigoletto; Suaad Abd-Elhadi; Hava Glickstein; Alexander Friedman; Geidy E Serrano; Thomas G Beach; Ronit Sharon
Journal:  Mol Neurodegener       Date:  2020-03-30       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.